← All trials
NCT06494475
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 17, 2024
- Primary completion
- Jun 21, 2025
- Completion date
- Jun 21, 2025
- First posted
- Jul 10, 2024
- Last posted
- Jul 10, 2024
- Enrollment
- 564
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Minervax ApSLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.